WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Boeing in the spotlight as Congress calls a whistleblower to testify about defects in planesTaylor Swift's upcoming album The Tortured Poets Department will be promoted with a multiPolice seeking arrest of Pennsylvania Rep. Kevin BoyleMbappé scores twice as PSG beats Barcelona to reach Champions League semisTaylor Swift's New Heights Coachella cap is back in stockTrump to meet with Polish president Duda as NATO leaders call for additional support for UkraineChina's top legislator meets DPRK top leaderQueen Mary and King Frederik of Denmark join Queen Margrethe to celebrate her 84th birthdayDortmund digs deep to beat Atlético 4China's political advisors discuss foundations of food security
2.7037s , 5763.2421875 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,World Winds news portal